Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F98G3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,907
Award facts
- Contract value 100% obligated
- $13,907.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,907.21 firm fixed-price delivery order to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 30, 2026, for the supply of Dupixent 300 mg/2 mL pen injections. The contract was competitively awarded with no set-aside designation and is scheduled for completion by February 2, 2026. Performance will be executed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical and medical commodities to military healthcare systems globally.
Dupixent (dupilumab) is a biologic medication used to treat moderate-to-severe eczema, asthma, and chronic rhinosinusitis, making this delivery order part of DLA's broader pharmaceutical supply chain supporting military treatment facilities and veteran healthcare programs. AmerSourceBergen Drug Corp, as a subsidiary of Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement, demonstrating capability to meet government requirements for specialized medications across multiple therapeutic domains through open competition.
Quick answers
Who was awarded contract SPE2DR26F98G3?
SPE2DR26F98G3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F98G3 worth?
The government has obligated $13,907 on SPE2DR26F98G3.
Is contract SPE2DR26F98G3 an order under another contract?
Yes. SPE2DR26F98G3 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F98G3 competed?
The extent of competition for SPE2DR26F98G3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award